Cardama Alfonso Quintas's Form 4 filing
TCR2 Therapeutics Inc.TCRR · filed Dec 13, 2022
- Accession no.
- 0000899243-22-038387
- Filed
- Dec 13, 2022
- Trade date
- Dec 9-13, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions. Open-market sales total $15.1K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Cardama Alfonso QuintasCIK 0001760104 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 9, 2022 | Common Stock | SSaleDisposed | −4,461 | $1.13 | −$5,040.93 | 118,797 | Direct | |
| Dec 12, 2022 | Common Stock | SSaleDisposed | −4,586 | $1.10 | −$5,044.6 | 114,211 | Direct | |
| Dec 13, 2022 | Common Stock | SSaleDisposed | −4,752 | $1.06 | −$5,037.12 | 109,459 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.